HumuLIN 70/30 KwikPen
Generic name: Insulin Isophane And Insulin Regular
Drug class:
Insulin
Usage of HumuLIN 70/30 KwikPen
Insulin is a hormone that works by lowering levels of glucose (sugar) in the blood. Insulin isophane is a intermediate-acting insulin. Insulin regular is an short-acting insulin. This combination insulin starts to work within 10 to 20 minutes after injection, peaks in 2 hours, and keeps working for up to 24 hours.
HumuLIN 70/30 KwikPen is a combination medicine used to improve blood sugar control in adults with diabetes mellitus.
HumuLIN 70/30 KwikPen may also be used for purposes not listed in this medication guide.
HumuLIN 70/30 KwikPen side effects
Get emergency medical help if you have signs of insulin allergy: redness or swelling where an injection was given, itchy skin rash over the entire body, trouble breathing, chest tightness, feeling like you might pass out, or swelling in your tongue or throat.
HumuLIN 70/30 KwikPen may cause serious side effects. Call your doctor at once if you have:
Common side effects of HumuLIN 70/30 KwikPen may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking HumuLIN 70/30 KwikPen
You should not use this medicine if you are allergic to insulin, or if you are having an episode of hypoglycemia (low blood sugar).
This medicine is not approved for use by anyone younger than 18 years old.
Tell your doctor if you have ever had:
Tell your doctor if you also take pioglitazone or rosiglitazone (sometimes contained in combinations with Glimepiride or metformin). Taking certain oral diabetes medicines while you are using insulin may increase your risk of serious heart problems.
Tell your doctor if you are pregnant or breastfeeding.
Follow your doctor's instructions about using insulin if you are pregnant or you become pregnant. Controlling diabetes is very important during pregnancy, and having high blood sugar may cause complications in both the mother and the baby.
Relate drugs
- Admelog
- Afrezza
- Apidra
- Myxredlin
- Basaglar
- Basaglar KwikPen
- Basaglar Tempo Pen
- Exubera
- Fiasp
- Humalog
- Humalog Mix
- Humalog Mix 50/50
- Humalog Mix 50/50 KwikPen
- Humalog Mix 75/25
- Humalog Mix 75/25 KwikPen
- HumuLIN 50/50
- Humulin 70/30
- HumuLIN 70/30 KwikPen
- Humulin N
- HumuLIN N KwikPen
- Humulin R
- Humulin R (Concentrated) U-500
- HumuLIN R KwikPen (Concentrated) U-500
- Insulin Aspart
- Insulin aspart and insulin aspart protamine
- Insulin aspart and insulin degludec
- Insulin aspart protamine and insulin aspart
- Insulin aspart, recombinant
- Insulin degludec
- Insulin Detemir
- Insulin glargine
- Insulin Glargine Prefilled Pen
- Insulin Glargine Solostar Pen
- Insulin glargine, recombinant
- Insulin glargine-aglr, recombinant
- Insulin glargine-yfgn, recombinant
- Insulin glulisine
- Insulin human inhaled
- Insulin human isophane (nph)
- Insulin human regular
- Insulin inhalation
- Insulin isophane
- Insulin isophane and insulin regular
- Insulin Lispro
- Insulin lispro and insulin lispro protamine
- Insulin lispro protamine and insulin lispro
- Insulin lispro-aabc
- Insulin nph and regular
- Insulin Regular
- Insulin regular, concentrated U-500
- Lantus
- Lantus SoloStar
- Lantus Solostar Pen
- Levemir
- Levemir Flexpen
- Levemir FlexTouch
- Lispro-PFC
- Lyumjev
- Lyumjev Kwikpen (Insulin lispro Intravenous, Subcutaneous)
- Lyumjev Kwikpen (Insulin lispro-aabc Intravenous, Subcutaneous)
- Novolin 70/30
- Novolin N
- Novolin R
- NovoLog
- NovoLog FlexPen
- NovoLog Mix 70/30
- NovoLog Mix 70/30 FlexPen
- NovoLog PenFill
- ReliOn/Novolin 70/30
- ReliOn/NovoLIN N
- Rezvoglar KwikPen (Insulin glargine, recombinant Subcutaneous)
- Rezvoglar KwikPen (Insulin glargine-aglr, recombinant Subcutaneous)
- Ryzodeg 70/30
- Semglee
- Semglee (Insulin glargine, recombinant Subcutaneous)
- Semglee (Insulin glargine-yfgn, recombinant Subcutaneous)
- Semglee (Prefilled Pen)
- Semglee (Vial)
- Semglee Pen (Insulin glargine, recombinant Subcutaneous)
- Semglee Pen (Insulin glargine-yfgn, recombinant Subcutaneous)
- Toujeo
- Toujeo Max SoloStar
- Tresiba FlexTouch
How to use HumuLIN 70/30 KwikPen
Follow all directions on your prescription label and read all medication guides or instruction sheets. Use the medicine exactly as directed.
Insulin is injected under the skin. A healthcare provider can teach you how to properly use the medication by yourself.
Do not give HumuLIN 70/30 KwikPen with an insulin pump.
Read and carefully follow any Instructions for Use provided with your medicine. Ask your doctor or pharmacist if you don't understand all instructions.
This insulin should look cloudy after mixing. Do not use the mixture if it looks clear or has particles in it. Call your pharmacist for new medicine.
Your care provider will show you where on your body to inject HumuLIN 70/30 KwikPen. Use a different place each time you give an injection. Do not inject into the same place two times in a row.
Do not inject this medicine into skin that is damaged, tender, bruised, pitted, thickened, scaly, or has a scar or hard lump.
After using HumuLIN 70/30 KwikPen, you should eat a meal within 30 to 45 minutes.
If you use an injection pen, use only the injection pen that comes with this insulin. Attach a new needle before each use. Do not transfer the insulin from the pen into a syringe.
Never share an injection pen or syringe with another person, even if the needle has been changed. Sharing these devices can allow infections or disease to pass from one person to another.
You may have low blood sugar (hypoglycemia) and feel very hungry, dizzy, irritable, confused, anxious, or shaky. To quickly treat hypoglycemia, eat or drink a fast-acting source of sugar (fruit juice, hard candy, crackers, raisins, or non-diet soda).
Your doctor may prescribe a Glucagon injection kit in case you have severe hypoglycemia. Be sure your family or close friends know how to give you this injection in an emergency.
Also watch for signs of high blood sugar (hyperglycemia) such as increased thirst or urination.
Blood sugar levels can be affected by stress, illness, surgery, exercise, alcohol use, or skipping meals. Ask your doctor before changing your dose or medication schedule.
Insulin is only part of a treatment program that may also include diet, exercise, weight control, blood sugar testing, and special medical care. Follow your doctor's instructions very closely.
Keep this medicine in its original container protected from heat and light. Do not draw insulin from a vial into a syringe until you are ready to give an injection. Do not freeze insulin or store it near the cooling element in a refrigerator. Throw away any insulin that has been frozen.
Storing unopened (not in use) HumuLIN 70/30 KwikPen:
Storing opened (in use) HumuLIN 70/30 KwikPen:
Use a needle and syringe only once and then place them in a puncture-proof "sharps" container. Follow state or local laws about how to dispose of this container. Keep it out of the reach of children and pets.
In case of emergency, wear or carry medical identification to let others know you have diabetes.
Warnings
You should not use HumuLIN 70/30 KwikPen if you are having an episode of low blood sugar.
Never share an injection pen or syringe with another person, even if the needle has been changed.
What other drugs will affect HumuLIN 70/30 KwikPen
This insulin may not work as well when you use other medicines at the same time. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Some drugs can also cause you to have fewer symptoms of hypoglycemia, making it harder to tell when your blood sugar is low. Not all possible interactions are listed here. Tell your doctor about all medicines you start or stop using.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions